2022-11-012023-10-312023-10-31false08729455SUSSEX OSTEOPATHS LTD2024-07-0586900iso4217:GBPxbrli:pure087294552022-11-01087294552023-10-31087294552022-11-012023-10-31087294552021-11-01087294552022-10-31087294552021-11-012022-10-3108729455bus:SmallEntities2022-11-012023-10-3108729455bus:AuditExempt-NoAccountantsReport2022-11-012023-10-3108729455bus:FullAccounts2022-11-012023-10-3108729455bus:PrivateLimitedCompanyLtd2022-11-012023-10-3108729455core:WithinOneYear2023-10-3108729455core:AfterOneYear2023-10-3108729455core:WithinOneYear2022-10-3108729455core:AfterOneYear2022-10-3108729455core:ShareCapital2023-10-3108729455core:SharePremium2023-10-3108729455core:RevaluationReserve2023-10-3108729455core:OtherReservesSubtotal2023-10-3108729455core:RetainedEarningsAccumulatedLosses2023-10-3108729455core:ShareCapital2022-10-3108729455core:SharePremium2022-10-3108729455core:RevaluationReserve2022-10-3108729455core:OtherReservesSubtotal2022-10-3108729455core:RetainedEarningsAccumulatedLosses2022-10-3108729455core:LandBuildings2023-10-3108729455core:PlantMachinery2023-10-3108729455core:Vehicles2023-10-3108729455core:FurnitureFittings2023-10-3108729455core:OfficeEquipment2023-10-3108729455core:NetGoodwill2023-10-3108729455core:IntangibleAssetsOtherThanGoodwill2023-10-3108729455core:ListedExchangeTraded2023-10-3108729455core:UnlistedNon-exchangeTraded2023-10-3108729455core:LandBuildings2022-10-3108729455core:PlantMachinery2022-10-3108729455core:Vehicles2022-10-3108729455core:FurnitureFittings2022-10-3108729455core:OfficeEquipment2022-10-3108729455core:NetGoodwill2022-10-3108729455core:IntangibleAssetsOtherThanGoodwill2022-10-3108729455core:ListedExchangeTraded2022-10-3108729455core:UnlistedNon-exchangeTraded2022-10-3108729455core:LandBuildings2022-11-012023-10-3108729455core:PlantMachinery2022-11-012023-10-3108729455core:Vehicles2022-11-012023-10-3108729455core:FurnitureFittings2022-11-012023-10-3108729455core:OfficeEquipment2022-11-012023-10-3108729455core:NetGoodwill2022-11-012023-10-3108729455core:IntangibleAssetsOtherThanGoodwill2022-11-012023-10-3108729455core:ListedExchangeTraded2022-11-012023-10-3108729455core:UnlistedNon-exchangeTraded2022-11-012023-10-3108729455core:MoreThanFiveYears2022-11-012023-10-3108729455core:Non-currentFinancialInstruments2023-10-3108729455core:Non-currentFinancialInstruments2022-10-3108729455dpl:CostSales2022-11-012023-10-3108729455dpl:DistributionCosts2022-11-012023-10-3108729455core:LandBuildings2022-11-012023-10-3108729455core:PlantMachinery2022-11-012023-10-3108729455core:Vehicles2022-11-012023-10-3108729455core:FurnitureFittings2022-11-012023-10-3108729455core:OfficeEquipment2022-11-012023-10-3108729455dpl:AdministrativeExpenses2022-11-012023-10-3108729455core:NetGoodwill2022-11-012023-10-3108729455core:IntangibleAssetsOtherThanGoodwill2022-11-012023-10-3108729455dpl:GroupUndertakings2022-11-012023-10-3108729455dpl:ParticipatingInterests2022-11-012023-10-3108729455dpl:GroupUndertakingscore:ListedExchangeTraded2022-11-012023-10-3108729455core:ListedExchangeTraded2022-11-012023-10-3108729455dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-11-012023-10-3108729455core:UnlistedNon-exchangeTraded2022-11-012023-10-3108729455dpl:CostSales2021-11-012022-10-3108729455dpl:DistributionCosts2021-11-012022-10-3108729455core:LandBuildings2021-11-012022-10-3108729455core:PlantMachinery2021-11-012022-10-3108729455core:Vehicles2021-11-012022-10-3108729455core:FurnitureFittings2021-11-012022-10-3108729455core:OfficeEquipment2021-11-012022-10-3108729455dpl:AdministrativeExpenses2021-11-012022-10-3108729455core:NetGoodwill2021-11-012022-10-3108729455core:IntangibleAssetsOtherThanGoodwill2021-11-012022-10-3108729455dpl:GroupUndertakings2021-11-012022-10-3108729455dpl:ParticipatingInterests2021-11-012022-10-3108729455dpl:GroupUndertakingscore:ListedExchangeTraded2021-11-012022-10-3108729455core:ListedExchangeTraded2021-11-012022-10-3108729455dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-11-012022-10-3108729455core:UnlistedNon-exchangeTraded2021-11-012022-10-3108729455core:NetGoodwill2023-10-3108729455core:IntangibleAssetsOtherThanGoodwill2023-10-3108729455core:LandBuildings2023-10-3108729455core:PlantMachinery2023-10-3108729455core:Vehicles2023-10-3108729455core:FurnitureFittings2023-10-3108729455core:OfficeEquipment2023-10-3108729455core:AfterOneYear2023-10-3108729455core:WithinOneYear2023-10-3108729455core:ListedExchangeTraded2023-10-3108729455core:UnlistedNon-exchangeTraded2023-10-3108729455core:ShareCapital2023-10-3108729455core:SharePremium2023-10-3108729455core:RevaluationReserve2023-10-3108729455core:OtherReservesSubtotal2023-10-3108729455core:RetainedEarningsAccumulatedLosses2023-10-3108729455core:NetGoodwill2022-10-3108729455core:IntangibleAssetsOtherThanGoodwill2022-10-3108729455core:LandBuildings2022-10-3108729455core:PlantMachinery2022-10-3108729455core:Vehicles2022-10-3108729455core:FurnitureFittings2022-10-3108729455core:OfficeEquipment2022-10-3108729455core:AfterOneYear2022-10-3108729455core:WithinOneYear2022-10-3108729455core:ListedExchangeTraded2022-10-3108729455core:UnlistedNon-exchangeTraded2022-10-3108729455core:ShareCapital2022-10-3108729455core:SharePremium2022-10-3108729455core:RevaluationReserve2022-10-3108729455core:OtherReservesSubtotal2022-10-3108729455core:RetainedEarningsAccumulatedLosses2022-10-3108729455core:NetGoodwill2021-11-0108729455core:IntangibleAssetsOtherThanGoodwill2021-11-0108729455core:LandBuildings2021-11-0108729455core:PlantMachinery2021-11-0108729455core:Vehicles2021-11-0108729455core:FurnitureFittings2021-11-0108729455core:OfficeEquipment2021-11-0108729455core:AfterOneYear2021-11-0108729455core:WithinOneYear2021-11-0108729455core:ListedExchangeTraded2021-11-0108729455core:UnlistedNon-exchangeTraded2021-11-0108729455core:ShareCapital2021-11-0108729455core:SharePremium2021-11-0108729455core:RevaluationReserve2021-11-0108729455core:OtherReservesSubtotal2021-11-0108729455core:RetainedEarningsAccumulatedLosses2021-11-0108729455core:AfterOneYear2022-11-012023-10-3108729455core:WithinOneYear2022-11-012023-10-3108729455core:Non-currentFinancialInstrumentscore:CostValuation2022-11-012023-10-3108729455core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-11-012023-10-3108729455core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-11-012023-10-3108729455core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-11-012023-10-3108729455core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-11-012023-10-3108729455core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-11-012023-10-3108729455core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-11-012023-10-3108729455core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-11-012023-10-3108729455core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-11-012023-10-3108729455core:Non-currentFinancialInstrumentscore:CostValuation2023-10-3108729455core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-10-3108729455core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-10-3108729455core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-10-3108729455core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-10-3108729455core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-10-3108729455core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-10-3108729455core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-10-3108729455core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-10-3108729455core:Non-currentFinancialInstrumentscore:CostValuation2022-10-3108729455core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-10-3108729455core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-10-3108729455core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-10-3108729455core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-10-3108729455core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-10-3108729455core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-10-3108729455core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-10-3108729455core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-10-3108729455bus:Director12022-11-012023-10-3108729455bus:Director22022-11-012023-10-3108729455core:FurnitureFittingsToolsEquipment2022-10-3108729455core:FurnitureFittingsToolsEquipment2022-11-012023-10-3108729455core:FurnitureFittingsToolsEquipment2023-10-31

SUSSEX OSTEOPATHS LTD

Registered Number
08729455
(England and Wales)

Unaudited Financial Statements for the Year ended
31 October 2023

SUSSEX OSTEOPATHS LTD
Company Information
for the year from 1 November 2022 to 31 October 2023

Directors

GATERELL, Callum Andre
TAYLOR, Sophie Louise

Registered Address

12a Marlborough Place
Brighton
BN1 1WN

Registered Number

08729455 (England and Wales)
SUSSEX OSTEOPATHS LTD
Balance Sheet as at
31 October 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Tangible assets345,08212,660
45,08212,660
Current assets
Debtors43,000-
Cash at bank and on hand27,49826,258
30,49826,258
Creditors amounts falling due within one year5(24,679)(18,132)
Net current assets (liabilities)5,8198,126
Total assets less current liabilities50,90120,786
Creditors amounts falling due after one year6(13,950)(19,350)
Net assets36,9511,436
Capital and reserves
Called up share capital11
Profit and loss account36,9501,435
Shareholders' funds36,9511,436
The financial statements were approved and authorised for issue by the Board of Directors on 5 July 2024, and are signed on its behalf by:
GATERELL, Callum Andre
Director
Registered Company No. 08729455
SUSSEX OSTEOPATHS LTD
Notes to the Financial Statements
for the year ended 31 October 2023

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Fixtures and fittings25
Finance leases and hire purchase contracts
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.
2.Average number of employees

20232022
Average number of employees during the year22
3.Tangible fixed assets

Land & buildings

Fixtures & fittings

Total

£££
Cost or valuation
At 01 November 22-21,96521,965
Additions35,587-35,587
At 31 October 2335,58721,96557,552
Depreciation and impairment
At 01 November 22-9,3059,305
Charge for year-3,1653,165
At 31 October 23-12,47012,470
Net book value
At 31 October 2335,5879,49545,082
At 31 October 22-12,66012,660
4.Debtors: amounts due within one year

2023

2022

££
Other debtors3,000-
Total3,000-
5.Creditors: amounts due within one year

2023

2022

££
Taxation and social security23,67417,148
Other creditors3311
Accrued liabilities and deferred income972973
Total24,67918,132
6.Creditors: amounts due after one year

2023

2022

££
Bank borrowings and overdrafts13,95019,350
Total13,95019,350